» Articles » PMID: 18635892

Body Mass and Glucocorticoid Response in Asthma

Overview
Specialty Critical Care
Date 2008 Jul 19
PMID 18635892
Citations 118
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Obesity may alter glucocorticoid response in asthma.

Objectives: To evaluate the relationship between body mass index (BMI, kg/m(2)) and glucocorticoid response in subjects with and without asthma.

Methods: Nonsmoking adult subjects underwent characterization of lung function, BMI, and spirometric response to prednisone. Dexamethasone (DEX, 10(-6) M)-induced mitogen-activated protein kinase phosphatase-1 (MKP-1) and baseline tumor necrosis factor (TNF)-alpha expression were evaluated by polymerase chain reaction in peripheral blood mononuclear cells (PBMCs) and bronchoalveolar lavage cells. The relationship between BMI and expression of MKP-1 and TNF-alpha was analyzed.

Measurements And Main Results: A total of 45 nonsmoking adults, 33 with asthma (mean [SD] FEV(1)% of 70.7 [9.8]%) and 12 without asthma were enrolled. DEX-induced PBMC MKP-1 expression was reduced in overweight/obese versus lean patients with asthma, with mean (+/- SEM) fold-induction of 3.11 (+/-0.46) versus 5.27 (+/-0.66), respectively (P = 0.01). In patients with asthma, regression analysis revealed a -0.16 (+/-0.08)-fold decrease in DEX-induced MKP-1 per unit BMI increase (P = 0.04). PBMC TNF-alpha expression increased as BMI increased in subjects with asthma, with a 0.27 unit increase in log (TNF-alpha [ng/ml]) per unit BMI increase (P = 0.01). The ratio of PBMC log (TNF-alpha):DEX-induced MKP-1 also increased as BMI increased in patients with asthma (+0.09 +/- 0.02; P = 0.004). In bronchoalveolar lavage cells, DEX-induced MKP-1 expression was also reduced in overweight/obese versus lean patients with asthma (1.36 +/- 0.09-fold vs. 1.76 +/- 0.15-fold induction; P = 0.05). Similar findings were not observed in control subjects without asthma.

Conclusions: Elevated BMI is associated with blunted in vitro response to dexamethasone in overweight and obese patients with asthma.

Citing Articles

Intramuscular methylprednisolone in hand osteoarthritis: a retrospective cohort study.

Hartog M, van Berkel J, van den Bemt B, van den Ende C, Popa C Rheumatol Adv Pract. 2024; 8(4):rkae136.

PMID: 39588297 PMC: 11588207. DOI: 10.1093/rap/rkae136.


Leptin augments IL-13-induced airway eotaxins and submucosal eosinophilia in obesity-associated asthma.

Ingram J, McQuade V, Weiss J, Womble J, Ihrie M, Zhao K J Allergy Clin Immunol. 2024; 155(3):819-833.e10.

PMID: 39581293 PMC: 11875949. DOI: 10.1016/j.jaci.2024.10.039.


Association of Obesity and Severe Asthma in Adults.

Olejnik A, Kuznar-Kaminska B J Clin Med. 2024; 13(12).

PMID: 38930006 PMC: 11204497. DOI: 10.3390/jcm13123474.


Clinical Remission in Patients Affected by Severe Eosinophilic Asthma on Dupilumab Therapy: A Long-Term Real-Life Study.

Quarato C, Tondo P, Lacedonia D, Soccio P, Fuso P, Sabato E J Clin Med. 2024; 13(1).

PMID: 38202298 PMC: 10780210. DOI: 10.3390/jcm13010291.


Obesity-associated Airway Hyperresponsiveness: Mechanisms Underlying Inflammatory Markers and Possible Pharmacological Interventions.

Pathak M, Patowary P, Chattopadhyay P, Barbhuiyan P, Islam J, Gogoi J Endocr Metab Immune Disord Drug Targets. 2023; 24(9):1053-1068.

PMID: 37957906 DOI: 10.2174/0118715303256440231028072049.


References
1.
Peters-Golden M, Swern A, Bird S, Hustad C, Grant E, Edelman J . Influence of body mass index on the response to asthma controller agents. Eur Respir J. 2006; 27(3):495-503. DOI: 10.1183/09031936.06.00077205. View

2.
Berry M, Hargadon B, Shelley M, Parker D, Shaw D, Green R . Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med. 2006; 354(7):697-708. DOI: 10.1056/NEJMoa050580. View

3.
Nomura I, Goleva E, Howell M, Hamid Q, Ong P, Hall C . Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol. 2003; 171(6):3262-9. DOI: 10.4049/jimmunol.171.6.3262. View

4.
Crapo R, Casaburi R, Coates A, Enright P, Hankinson J, Irvin C . Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000; 161(1):309-29. DOI: 10.1164/ajrccm.161.1.ats11-99. View

5.
Wellen K, Hotamisligil G . Obesity-induced inflammatory changes in adipose tissue. J Clin Invest. 2003; 112(12):1785-8. PMC: 297006. DOI: 10.1172/JCI20514. View